Pretreating the NCMs with rapamycin could significantly decrease the mRNA level of ANP and BNP (Figure 4(a)), indicating that mTOR was involved in the PA-induced cardiac hypertrophy. The gene discussed is NPPB; the disease is cardiac hypertrophy.